Market Overview
Global Ventricular Assist Devices Market is expected to reach at a CAGR of 10% during the forecast period 2026-2033.
A ventricular assist device (VAD) is a mechanical pump that is used to support heart function and blood flow in people with weak or failing hearts. It is used either to partially or to completely replace the function of a failing heart.
VADs are designed to assist either the right ventricle (RVAD) or the left ventricle (LVAD) or to assist both ventricles (BiVAD). By relieving the heart's workload, a VAD can prolong life and improve symptoms such as fatigue and breathlessness.
Market Scope
| Metrics | Details |
| CAGR | High |
| Market Size | 2023-2033 |
| Market Estimation Forecast Period | 2026-2033 |
| Revenue Units | Value (US$ Mn) |
| Segments Covered | Product Type, Design, Application, End User, and Region |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Largest Region | Asia-Pacific |
| Fastest Growing Region | North America |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights. |
For more details on this report – Request for Sample
Market Dynamics
Increasing cardiac disease and heart failure burden
The increase in the number of cardiac diseases and the increase in the heart failure burden is expected to drive the market growth. These factors increase the demand for ventricular assist devices. Additionally, the increase in technological advancements and the increase in the approvals of the devices are also expected to drive the market.
High costs of devices and the procedures
Factors such as high cost and serious complications involved with the usage of ventricular assist devices such as blood clots and bleeding, are restricting the global ventricular assist devices market growth.
Ventricular Assist Devices Market Segment Analysis
The global ventricular assist devices market is segmented based on product type, design application, end-user and region.
Left ventricular assist device segment accounted for 48.3% of the market share
The left ventricular assist devices segment is expected to hold a dominant share in the global ventricular assist devices market because of the advantages of the LAVD over other types.. The left ventricular assist device (LVAD) is the most common device applied to a defective heart (it is sufficient in most cases.
Left Ventricular Assist Devices (LVADs) are mechanical devices that are implanted in patients with advanced heart failure, help the heart pump blood more effectively, and could benefit patients with advanced heart failure as they await donors. They improve the function of the kidneys, liver, brain, and other organs by increasing blood flow to the body.
Left Ventricular Assist Device (LVAD) helps the left side of the heart pump blood to a large blood vessel called the aorta and to the rest of the body.
Additionally, the increase in the number of heart diseases, an increase in the geriatric population, and the increase in the number of launches of the devices are expected to drive the segment’s growth. Thus, the above factors are expected to hold a significant position in the market share.
Ventricular Assist Devices Market Geographical Share
North America is expected to hold a significant position in the global ventricular assist devices market share
North America holds a dominant share in the ventricular assist devices market share owing to technological advancements and, an increase in the burden of heart diseases and is expected to continue throughout the forecast period.
Thus, an increase in the burden of heart diseases, and also increase in the advancements in the region, and the presence of major companies in the region are expected to drive market growth in the region.
Ventricular Assist Devices Market Companies
The leading companies with a significant market share include Abbott Laboratories, Abiomed Inc, Berlin Heart GmbH, Medtronic Plc, Jarvik Heart, Inc., EVAHEART, INC., Cirtec, CorWave SA, Calon Cardio-Technology Ltd, and Teleflex Incorporated.
Key Developments
- January 2026: Abiomed (Johnson & Johnson) announced advancements in their Impella RP system for right ventricular support, featuring improved pump durability and reduced hemolysis rates through next-generation motor technology. This development enhances outcomes for patients with biventricular failure as a bridge to recovery or transplant. Clinical data showed a 20% improvement in 30-day survival rates compared to prior models.
- December 2025: Enginprime Medical initiated the first-in-human study of OpusOne pVAD, a percutaneous ventricular assist device designed for rapid deployment in acute heart failure cases. The device emphasizes minimally invasive insertion and high-flow support up to 5 L/min with low complication risks. Early results indicate successful safety and performance in initial patients.
- September 2025: FineHeart commenced clinical trials for FlowMaker LVAD in France, introducing turbine-based technology that synchronizes with native heart contraction for lower energy use and reduced thrombosis. Aiming for CE mark by 2028, it supports long-term destination therapy with physiologic pulsatility. Trials focus on outpatient mobility and quality-of-life improvements.
Why Purchase the Report?
- To visualize the global ventricular assist devices market segmentation based on product type, design, application, end-user and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of ventricular assist devices market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global ventricular assist devices market report would provide approximately 69 tables, 68 figures, and 185 Pages.
Target Audience
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
